NASDAQ:GLMD - Galmed Pharmaceuticals Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $15.02 +1.01 (+7.21 %) (As of 07/19/2018 04:00 PM ET)Previous Close$14.01Today's Range$13.88 - $15.1752-Week Range$3.61 - $27.06Volume684,911 shsAverage Volume385,331 shsMarket Capitalization$233.53 millionP/E Ratio-15.33Dividend YieldN/ABeta2.65 Company ProfileFinancialsAnalyst RatingsEarnings HistoryHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Galmed Pharmaceuticals (NASDAQ:GLMD) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.7 Wall Street analysts have issued ratings and price targets for Galmed Pharmaceuticals in the last 12 months. Their average twelve-month price target is $38.50, suggesting that the stock has a possible upside of 156.32%. The high price target for GLMD is $59.00 and the low price target for GLMD is $19.00. There are currently 7 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 3.003.003.003.00Ratings Breakdown: 0 Sell Rating(s)0 Hold Rating(s)7 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)0 Hold Rating(s)4 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)0 Hold Rating(s)4 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)0 Hold Rating(s)4 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $38.50$31.00$22.25$20.75Price Target Upside: 156.32% upside76.24% upside313.57% upside105.85% upsideGalmed Pharmaceuticals (NASDAQ:GLMD) Consensus Price Target History Galmed Pharmaceuticals (NASDAQ:GLMD) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails7/13/2018Stifel NicolausInitiated CoverageBuy$35.00Medium7/12/2018Cantor FitzgeraldReiterated RatingOverweightLow7/12/2018Imperial CapitalInitiated CoverageOutperform$59.00High6/12/2018Maxim GroupBoost Price TargetBuy ➝ Buy$14.00 ➝ $30.00High6/12/2018SunTrust BanksBoost Price Target$15.00 ➝ $31.00High6/12/2018HC WainwrightBoost Price TargetBuy$24.00 ➝ $43.00N/A11/15/2017Roth CapitalInitiated CoverageBuy ➝ Buy$32.00N/A10/6/2017Seaport Global SecuritiesReiterated RatingBuy$19.00N/A8/5/2016FBR & CoSet Price TargetBuy$20.00N/A(Data available from 7/19/2016 forward) This page was last updated on 7/19/2018 by MarketBeat.com StaffFeatured Article: Should I follow buy, hold and sell recommendations?